心脉医疗 (688016.SH) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	1.4B	1.4B	1.2B	1.2B	896.5M
Cost of Revenue	389.1M	390.6M	325.6M	279.6M	222.5M
Gross Profit	999.6M	960.1M	880.7M	907.6M	674.0M
Operating Expenses
R&D Expense	74.0M	67.8M	93.8M	172.9M	137.5M
SG&A Expense	—	—	—	—	—
General & Admin Expense	79.4M	82.0M	93.4M	55.0M	46.0M
Selling & Marketing Expense	210.1M	208.3M	156.8M	130.2M	104.0M
Other Expenses	—	—	—	—	—
Total Operating Expenses	374.7M	365.9M	337.9M	361.7M	284.9M
Cost and Expenses	763.8M	756.5M	663.4M	641.3M	507.5M
Operating Income (EBIT)	683.1M	654.0M	661.2M	573.9M	415.2M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	682.4M	653.5M	652.2M	572.3M	413.9M
Income Tax Expense	103.1M	98.8M	159.4M	85.1M	61.8M
Bottom Line
Net Income	588.5M	563.3M	502.1M	492.4M	356.9M
Earnings from Cont. Ops	579.3M	554.7M	492.7M	487.2M	352.1M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	588.5M	563.3M	502.1M	492.4M	356.9M
Per Share
Basic EPS	CN¥4.83	CN¥4.65	CN¥4.07	CN¥6.81	CN¥4.96
Diluted EPS	CN¥4.83	CN¥4.65	CN¥4.07	CN¥6.81	CN¥4.96
Revenue Per Share	CN¥11.48	CN¥11.15	CN¥9.78	CN¥16.42	CN¥12.46
Shares
Basic Shares Outstanding	121.0M	121.1M	123.4M	72.3M	72.0M
Diluted Shares Outstanding	121.0M	121.1M	123.4M	72.3M	72.0M
Profitability Metrics
EBITDA	—	731.7M	709.9M	608.8M	448.7M
D&A	—	77.7M	48.8M	35.0M	33.5M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026